| Positive Rankings |
Estimated Revenue Growth
Syndax Pharmaceuticals rank is 133 |
Low vPut/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.24 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 525. |
Debt-to-Equity
Syndax Pharmaceuticals rank is 709 |
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Syndax Pharmaceuticals is ranked 793. |
Up EPS Surprise
Syndax Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings. |
Low Put/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.59 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 1050. |
Price-to-Book
Syndax Pharmaceuticals rank is 1891 |
| Negative Rankings |
Negative Net Margin
Syndax Pharmaceuticals rank is 102 |
Price-to-Sales
Syndax Pharmaceuticals rank is 142 |
90 Day Loss
Syndax Pharmaceuticals rank is 406 |
Negative ROE
Syndax Pharmaceuticals rank is 547 |
Negative ROA
Syndax Pharmaceuticals rank is 580 |
10 Day Loss
Syndax Pharmaceuticals rank is 677 |
